← All organizations

BioAnaLab

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 1, 2008

Acquired by Millipore → Merck KGaA → Merck Serono on Jan 1, 2009

Timeline

2000s

Jan 1, 2002
BioAnaLab— Founded
Jan 1, 2006
Merck Serono— Now
Jan 1, 2009
Millipore— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 3 (1 own, 0 via acquisition)

cmv-specific t-cells

Indications

Studied for

Cytomegalovirus Infections

Recent trials (1)

NCT01077908CollaboratorPhase 3Jul 1, 2008

Details

Founded: Oxford, GB Jan 1, 2002
Last known activity: Jul 1, 2008